Although reduction of SETD2 may partly contribute to HOTAIR-medicated promotion of liver cancer stem cell growth, our findings in this study provide novel evidence for an active role of SETD2 in HOTAIR-mediated promotion of liver cancer stem cell growth. The gene discussed is SETD2; the disease is liver cancer.